B. Nguyen

发表

The effects of diminishing albumin binding to some Endothelin receptor antagonists.

K. Marsh, J. R. Wu-wong, W. Chiou, 1998, Life sciences.

Bile acid conjugates of a nonsteroidal glucocorticoid receptor modulator.

M. Emery, A. Goos-Nilsson, N. Tu, 2004, Bioorganic & medicinal chemistry letters.

Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivity.

A. Tasker, K. Marsh, C. Hutchins, 1999, Bioorganic & medicinal chemistry.

Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.

K. Marsh, M. Winn, D. Dixon, 1997, Journal of medicinal chemistry.

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.

S. Badylak, F. Haviv, J. Henkin, 2005, Journal of medicinal chemistry.

Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists.

K. Marsh, M. Winn, W. Chiou, 2001, Journal of medicinal chemistry.

Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead.

E B Reilly, K. Marsh, M. Gallatin, 2000, Journal of medicinal chemistry.

Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity.

A. Tasker, K. Marsh, M. Winn, 1999, Journal of Medicinal Chemistry.

Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chain.

K. Marsh, M. Winn, W. Chiou, 1999, Journal of medicinal chemistry.

2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.

V. Stoll, A. Molla, D. Kempf, 2009, Journal of medicinal chemistry.

Practical Preclinical Model for Assessing the Potential for Unconjugated Hyperbilirubinemia Produced by Human Immunodeficiency Virus Protease Inhibitors

J. Waring, D. Kempf, J. Randolph, 2006, Antimicrobial Agents and Chemotherapy.